Rigel Pharmaceuticals | Zobowiązania Handlowe





Zobowiązania Handlowe Zmiana Data
Agenus USD 85.29M 10.89M 2025-09
Amgen USD 20.89B 1.25B 2025-12
Anika Therapeutics USD 4.73M 39K 2025-09
Arrowhead Research USD 32.94M 15.26M 2025-12
AstraZeneca USD 25.28B 252M 2025-12
BioMarin Pharmaceutical USD 798.44M 114.19M 2025-09
Bristol-Myers Squibb USD 4.29B 1.14B 2025-09
Celldex Therapeutics USD 4.27M 2.19M 2025-09
Daiichi Sankyo JPY 568.5B 16.84B 2025-12
Eli Lilly USD 4.26B 186.5M 2025-09
Halozyme Therapeutics USD 15.36M 3.33M 2025-09
Heron Therapeutics USD 12.02M 20K 2025-09
Intrexon USD 4.85M 3.12M 2024-06
Ionis Pharmaceuticals USD 14.33M 8.47M 2025-09
Karyopharm Therapeutics USD 5.39M 2.8M 2025-09
Ligand Pharmaceuticals USD 27.76M 1.72M 2025-09
MacroGenics USD 5.94M 1.28M 2025-09
Neurocrine Biosciences USD 119.9M 15.3M 2025-09
Pfizer USD 5.02B 142M 2025-09
Regeneron Pharmaceuticals USD 5.83B 4.93B 2025-12
Rigel Pharmaceuticals USD 3.85M 3.44M 2025-09
Sangamo BioSciences USD 10.74M 7.46M 2025-06
Ultragenyx Pharmaceutical USD 40.57M 6.33M 2025-09
Veracyte USD 5.51M 5.94M 2025-09


Rigel Pharmaceuticals Zobowiązania Handlowe - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Feb 2026.